|
Volumn 16, Issue 5, 1996, Pages 437-442
|
Are down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
a b a c |
Author keywords
Congenital heart defect; Down syndrome; Serum screening
|
Indexed keywords
ALPHA FETOPROTEIN;
CHORIONIC GONADOTROPIN;
ESTRIOL;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONGENITAL HEART MALFORMATION;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DOWN SYNDROME;
FEMALE;
FETUS DEATH;
HIGH RISK PREGNANCY;
HUMAN;
MATERNAL SERUM;
NEURAL TUBE DEFECT;
NEWBORN DEATH;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SCREENING;
ADULT;
ALPHA-FETOPROTEINS;
CHORIONIC GONADOTROPIN;
CONFIDENCE INTERVALS;
DOWN SYNDROME;
ESTRIOL;
FEMALE;
FETAL DEATH;
FETAL DISEASES;
FETUS;
FOLLOW-UP STUDIES;
HEART DEFECTS, CONGENITAL;
HUMANS;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTER, SECOND;
PRENATAL DIAGNOSIS;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SURVIVAL RATE;
|
EID: 0029898218
PISSN: 01973851
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0223(199605)16:5<437::AID-PD889>3.0.CO;2-I Document Type: Article |
Times cited : (5)
|
References (9)
|